Diabetes drug could reduce chances of getting long COVID, study suggests

United States News News

Diabetes drug could reduce chances of getting long COVID, study suggests
United States Latest News,United States Headlines
  • 📰 SkyNews
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 67%

The US study showed that taking Metformin within three days of testing positive helped reduce chances of developing long COVID.

Taking a Type 2 diabetes drug while you have coronavirus reduces chances of getting long COVID by 40%, a new study has suggested.Scientists in the US have found that participants who took a two-week course within three days of a positive test result were less likely to still have coronavirus symptoms 10 months later.

The trial, published in the Lancet Infectious Diseases journal, was carried out on 1,126 overweight or obese people over the age of 30 between December 2020 and January 2022. It showed that only 6.3% of participants given the drug reported a long COVID diagnosis, compared with 10.4% of those who took a placebo - 40% fewer.

It is the first peer-reviewed phase three trial showing that taking medication while infected could help prevent long COVID. It supports previous studies that show metformin stops the virus from reproducing in lab conditions and reduces the chances of overweight or obese people being hospitalised or dying from COVID.with long COVID, which means they still reported symptoms after four weeks.suggested that most people with lingering symptoms find they are gone within a year.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SkyNews /  🏆 35. in UK

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weightOral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weightOrally administered semaglutide shows significant efficacy in reducing HbA1c and body weight in patients with type 2 diabetes compared to other treatments. The study includes a large number of participants from multiple trials.
Read more »

Gardening and dancing can help cut risk of diabetesGardening and dancing can help cut risk of diabetesAn active lifestyle could help millions of people at risk of diabetes and the positive impact of regular exercise even applies to those who are genetically vulnerable
Read more »

Patterns of Brain Aging in Middle-aged and Older Adults With Type 1 DiabetesThis cohort study evaluates neuroimaging markers of brain age and Alzheimer disease–like atrophy in participants with type 1 diabetes and assesses the association between cognition and brain aging indices.
Read more »

Older people with diabetes could be due up to £407 each month from DWPOlder people with diabetes could be due up to £407 each month from DWPMore than 17,200 older people are receiving financial help through Attendance Allowance for diabetes.
Read more »

Shifting towards precision medicine for type 2 diabetes dietary managementShifting towards precision medicine for type 2 diabetes dietary managementShifting towards precision medicine for type 2 diabetes dietary management Nutrients_MDPI UniEastFinland medicine typetwodiabetes diabetes type2 type2diabetes T2D
Read more »

Dr Michael Mosley: After my type 2 diabetes diagnosis, I totally changed my dietDr Michael Mosley: After my type 2 diabetes diagnosis, I totally changed my diet🖋️ DrMichaelMosley, author of ‘The 8-Week Blood Sugar Diet’, trained to be a doctor at the Royal Free Hospital before joining the BBC He tells KasiaLDelgadowhat he does to stay healthy – including breakfast kippers, cold showers, and his book group ⬇️
Read more »



Render Time: 2025-03-03 21:27:59